Form 4: Integra LifeSciences: Executive Receives Stock Units

Sentiment:

Statement of Changes in Beneficial Ownership


Harvinder Singh, EVP & President, SS at Integra LifeSciences Holdings Corp, was granted 5,590 restricted stock units.

Summary

  • Harvinder Singh, Executive Vice President & President, SS of Integra LifeSciences Holdings Corp (IART), received a grant of 5,590 restricted stock units (RSUs).
  • The RSUs were granted under the company's Fifth Amended and Restated 2003 Equity Incentive Plan.
  • These RSUs represent a contingent right to receive one share of the Issuer's common stock.
  • The RSUs will vest ratably over three years, with one-third vesting annually, contingent on continued service.
  • The grant date was July 1, 2026, and the filing was made on July 6, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation event rather than a significant financial or strategic development.

Positives

  • Grant of restricted stock units to a key executive, indicating continued investment in and retention of leadership.
  • The vesting schedule over three years suggests a long-term incentive aligned with company performance and executive commitment.

Risks

  • Vesting of RSUs is subject to the Reporting Person's continued service, meaning departure before vesting would result in forfeiture of the unvested portion.

Future Outlook

The RSUs are subject to a three-year vesting schedule, indicating a forward-looking incentive for continued service and performance.

Industry Context

StockSavvy.ai notes that grants of restricted stock units to senior executives are a common practice in the life sciences industry as a tool for executive compensation, retention, and aligning management interests with shareholder value.

Stakeholder Impact

  • Shareholders: The grant of RSUs is a form of compensation, which impacts dilution but is intended to incentivize leadership for long-term value creation.
  • Employees: The RSU grant is specific to Harvinder Singh and does not directly impact other employees, though it reflects the company's compensation philosophy.
  • Management: The RSUs provide a financial incentive for continued service and performance for Harvinder Singh.

Next Steps

  • Vesting of RSUs in three equal annual installments, subject to continued service.

Key Dates

DateDescription
07/01/2026Grant date of restricted stock units.
07/06/2026Date of filing for the statement of changes in beneficial ownership.

Keywords

Integra LifeSciences, IART, Form 4, Restricted Stock Units, RSU Grant, Executive Compensation, Equity Incentive Plan, Harvinder Singh

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.